Doctor profile · Federal record

Dr. Paul Adams, M.D.

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Flint, MI

  • NPI 1811952591
  • Accepts Medicare
  • 41 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
302 Kensington Ave
Flint, MI 485032044
(810) 762-8200
fax (810) 762-8202

Credentials & registration

NPPES · NUCC
NPI registered
April 2006 — 20 yrs on file
Profile last updated
August 25, 2020
Year of graduation
1985 — 41 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
Michigan #4301050024
Medicaid
MI #104396721

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1811952591. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
49,587
Distinct HCPCS
10
Medicare allowed
$271,196
HCPCS Description Services Patients Avg allowed
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 37,230 56 $1
J0897 Injection, denosumab, 1 mg 4,200 21 $23
J1453 Injection, fosaprepitant, 1 mg 2,700 11 $0
Q5106 Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units 1,078 14 $7
J1100 Injection, dexamethasone sodium phosphate, 1 mg 900 37 $0
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 887 339 $7
J2469 Injection, palonosetron hcl, 25 mcg 680 27 $1
99214 Established patient office or other outpatient visit, 30-39 minutes 583 219 $117
96372 Injection of drug or substance under skin or into muscle 248 70 $13
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 153 40 $27

In context: peer comparison

Among 5 peers in this city , average services per provider: 2,803. This provider delivers 18× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,129
Transactions
48
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Novartis Pharmaceuticals Corporation 18 $287.74
AstraZeneca Pharmaceuticals LP 4 $100.27
Genentech USA, Inc. 3 $67.21
E.R. Squibb & Sons, L.L.C. 3 $59.53
Janssen Biotech, Inc. 3 $55.78
Genmab U.S., Inc. 2 $52.61
Takeda Pharmaceuticals U.S.A., Inc. 2 $49.93
Incyte Corporation 3 $46.34
Celgene Corporation 2 $39.04
PFIZER INC. 2 $37.57
Lilly USA, LLC 2 $32.30
Dendreon Pharmaceuticals LLC 1 $32.17
Octapharma USA, Inc. 1 $31.78
GENZYME CORPORATION 1 $25.35
BeiGene USA, Inc. 1 $23.98

By nature of payment

Food and Beverage
$1,129

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
939
Patients
260
Total drug cost
$3,940,154
Drug Type Claims Patients Total cost
Anastrozole Generic 185 59 $19,921
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 125 50 $3,400
Lenalidomide Generic 70 0 $1,062,877
Morphine Sulfate Er (Morphine Sulfate) Brand 66 20 $2,191
Xtandi (Enzalutamide) Brand 62 0 $831,339
Revlimid (Lenalidomide) Brand 58 13 $1,302,687
Hydroxyurea Generic 52 17 $2,212
Exemestane Generic 50 15 $15,379
Gabapentin Generic 44 14 $682
Eliquis (Apixaban) Brand 40 11 $34,049

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Paul Adams's medical specialty?
Dr. Paul Adams practices Hematology & Oncology Physician in Flint, MI.
Where does Dr. Paul Adams practice?
Dr. Paul Adams practices at 302 Kensington Ave, Flint, MI 485032044. Office phone: 8107628200.
What is Dr. Paul Adams's NPI?
Dr. Paul Adams's National Provider Identifier (NPI) is 1811952591, issued by NPPES.
Does Dr. Paul Adams accept Medicare assignment?
Yes. Dr. Paul Adams accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Paul Adams commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, denosumab, 1 mg (HCPCS J0897); Injection, fosaprepitant, 1 mg (HCPCS J1453). Source: CMS Medicare Physician & Other Practitioners file.